Lapatinib cancer drug molecule

Lapatinib cancer drug molecule

A624/0479 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 39.7MB

Downloadable file size: 497.1KB

Price image Pricing

Please login to use the price calculator


Credit: DR TIM EVANS/SCIENCE PHOTO LIBRARY

Caption: Lapatinib cancer drug, Computer model of a molecule of the cancer drug lapatinib. Atoms are represented as rods and are colour-coded: carbon (pink), hydrogen (white), oxygen (green) nitrogen (neon pink) fluorine (light blue) chlorine (dark blue) and sulphur (cyan). This drug, which is marketed as Tycerb, is used to treat solid tumours such as breast and lung cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors. These drugs bind to tyrosine kinase growth factor receptors on the cancer cell's surface, inactivating them and so stopping cell growth and proliferation.

Release details: Model release not required. Property release not required.

Keywords: anti-cancer, biochemical, biochemistry, breast cancer, chemical, chemistry, chemotherapy, compound, compounds, drug, lapatinib, lung cancer, medical, medicine, molecular, molecular model, molecule, molecules, oncology, one, pharmaceutical, pharmaceutics, pharmacological, pharmacology, rod, rods, single, structure, tycerb, tyrosine kinase inhibitor

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.